Key Personnel | LUCASBIO

ABOUT
- ABOUT
- TECHNOLOGY
- PIPELINE
- CONTACT

Key Personnel

ABOUT

Key Personnel

ABOUT

Key Personnel

Keon-il Im / Research Director 18 SCI Research Articles 30 Patent Applications 4 Technology Transfer Cases 2 Government Projects as Principal Investigator 2 Industry-related Projects as Principal Investigator

Professional Experience

Research Director
Director of Research, LUCASBIO
Research Professor
Conversant Research Consorcium in Immunologic Disease (CRCID), Seoul St. Mary's Hospital, The Catholic University of Korea
Chief Research Scientist
Institute for Translational Research and Molecular Imaging College of Medicine, The Catholic University of Korea
Research Fellow
College of Medicine, The Catholic University of Korea

Education

Ph.D. in Immunology & Microbiology, Department of Biomedicine & Health Science, The Catholic University of Korea

Research Projects as Princpal Investigator

2020-2022	Study of TLR agonist to promote immune reconstitution following autologous hematopoietic stem cell transplantation and to improve elimination of minimal residual disease in relapse/refractory lymphoma patients
2020-2021	Evidence establishing study for the commercialization of placenta derived mesenchymal stroma cell therapy in graft-versus-host disease
2020-2021	Development of SARS-CoV-2 antigen specific dual targeting killer cell therapy for the treatment of COVID-19
2016-2019	Pathophysiological regulation of graft-versus-host disease through the inhibition of HMGB1 signaling pathway

Honors and Awards

2019	Gold Award, 2019 Seoul St. Mary’s Hospital R&D Fair
2019	Letter of Appreciation, The 6th Annual Meeting of the Korean Society of Experimental Hematology, A novel TLR5 agonist protects intestinal Lgr5+ stem cells through activates host-derived IL-22 in GVHD
2019	Best Reviewer Award, The Korean Society for Clinical Laboratory Science
2016	Outstanding Ph.D. Dissertation Award, The Catholic University of Korea, The free radical scavenger NecroX-7 attenuates acute graft-versus-host disease via reciprocal regulation of Th1/regulatory T cells and inhibition of HMGB1 release
2015	Young Investigator Award, The 6th Meeting of Asian Cellular Therapy Organization, Induction of mixed chimerism for solid-organ transplant tolerance: Comparison between combinatorial cell-based immune modulation using MSCs and Tregs and post-transplant cyclophosphamide
2015	Excellence Award, The 2nd Korean Society of Experimental Hematology, Biologic effect of high-mobility group Box 1 blockade in acute graft-versus-host disease
2015	Outstanding Graduate Student Award, 1st Brain Korea 21 Student Fellowship, The Catholic University of Korea

Technology Transfer as main inventor

2020	Connext, Composition for preventing or treating graft versus host disease comprising TLR5 agonist derived from flagellin as active ingredient. KR Patent Grant (No. 10-2169663-00-00)
2020	MitoImmune Therapeutics, Composition for preventing or treating mucositis comprising necrox as effective ingredient. KR Patent Grant (No.KR101718380B1), US Patent Grant (No.US10272092B2), EP Patent Grant (No.EP3216452A2), JP Patent Grant (No.6464277), CN Patent Grant (No.CN107073009A), WO Patent Application (No. WO2016072692)
2013	LG Life Sciences, A pharmaceutical composition for preventing and treating graft-versus-host disease. KR Patent Application (No. 10-2012-0047510), KR Patent Application (No. 10-2012-0047511), KR Patent Application (No. 10-2013-0031660)

Na-youn Kim/ Head of Product Development 25 SCI Research Articles 5 Patent Applications 1 Technology Transfer Case 1 Government-related Project

Professional Experience

2020 Product Development Division Director, LucasBio
2016-2020 Research Professor, Institute for Translational Research and Molecular Imaging, The Catholic Unversity of Korea
2011-2016 Researcher, Institute for Translational Research and Molecular Imaging, The Catholic Unversity of Korea

Education

2015-2016 The Catholic University of Korea Biomedical Science Immunology.Microbiology Ph.D
2012-2014 The Catholic University of Korea Biomedical Science Immunology.Microbiology M.S.
2008-2011 Emory University Biology B.S.

Research Abroad

2014	Visiting Researcher, Stanford University, Molecular Imaging Program at Stanford
2013	Visiting Researcher, Stanford University, Molecular Imaging Program at Stanford

Honors/Awards

2018	Best Young Abstract Award, European Society for Blood and Marrow Transplantation, Long term outcome of EBV-associated lymphoma treated with post-remission therapy using EBV LMP1 and LMP2a-specific CTLs
2017	Best Oral Presentation Award, The International Congress of BMT 2017 in conjunction with the Korean society of Blood and Marrow Transplantation, Robust production of cytomegalovirus pp65-specific T cells using a fully automated interferon gamma cytokine capture system
2016	Outstanding Ph.D. Dissertation Award, The Catholic University of Korea
2015	Best Abstract and Poster Award, The Korean Association of Immunologists 2015 Fall Conference, IL-21 expressing mesenchymal stem cells prevent lethal B-cell lymphoma through efficient delivery of IL-21 which redirects the immune system to target the tumor
2015	Best Poster Award, 2015 Seoul St. Mary’s Hospital R&BD Fair - IL-21 expressing mesenchymal stem cells prevent lethal B-cell lymphoma through efficient delivery of IL-21 which redirects the immune system to target the tumor
2015	Best Abstract Award, The 6th Meeting of Asian Cellular Therapy Organization - Long-term outcome of extranodal NK/T cell lymphoma patients treated with post-remission therapy using EBV LMP1 and LMP2a-specific CTLs
2015	Outstanding Graduate Student Award, The Catholic University of Korea
2012	Scholarship for adult stem cell research, The Committee for Life, Archdiocese of Seoul
2012	Outstanding Oral Presentation Award, The 52nd Spring Meeting, The Korean Society of Hematology

Tae-yeon Kim / Head of Business Development

Professional Experience

2022 Head of Business Development, LucasBio
2006-2002 Director of Biotechnology Laboratory, Boryung Biopharma
1989-2002 Chief Researcher, ,Mogam Institute for Biomedical Research

Education

1996-2001 KAIST, Molecular Virology, Ph.D.
1998-1990 Pusan National University, Microbiology, M.S.
1982-1988 Pusan National University, Microbiology, B.S

Research Projects as Principal Investigator

2020-2022	Development of Tdap Vaccine, Ministry of Health and Welfare
2017-2020	Localization of cell culture hepatitis A vaccine, Ministry of Health and Welfare
2015-2020	Development of cell culture technology for Japanese encephalitis vaccine, Ministry of Health and Welfare
	2008-2015 Development of adult Td vaccine, Ministry of Health and Welfare

Honors/Awards

2014	Minister of Health and Award for the Promotion of Health and Medical Technology

National R&D Committee Appointment

2018	2016-2022 Senior Member of Research Center for Response to Novel Virus Infection, Ministry of Science and Technology
2014-2016	Technical Member of Korea Technology Commercialization Advisory Group, Ministry of Trade, Industry and Energy
2010	Advisory Board Member of the Korea Centers for Disease Control and Prevention (KCDC)